Laobaixing Unveils Buyback and Employee Stock Plan, Target 75% Net Profit Growth by 2027
Laobaixing Pharmacy announced a share buyback and employee stock ownership plan on August 10. The incentive scheme sets performance targets requiring 2027 net profit to rise at least 75% and 2028 net profit at least 100% versus 2025, implying a compound annual growth rate of about 26% over three years. Retail pharmacy stocks rallied the next day, with leading players' shares performing strongly.
On the evening of August 10, Laobaixing announced a share buyback and employee stock ownership plan. The following day, the retail pharmacy sector rose notably, with shares of leading companies trading strongly.
The equity incentive plan sets explicit performance assessment targets: net profit for 2027 and 2028 must increase by no less than 75% and 100% respectively compared with 2025, corresponding to a compound annual growth rate of roughly 26% over the next three years.
On the operational front, same-store operations at leading companies continued to improve in July, inefficient stores were closed at a faster pace, and returning customer traffic at existing stores showed a clear recovery trend.
Why this event matters
The event has a measured impact on 1 industry. The strongest current signal is positive for Pharmacy Retail, with intensity 80/100 and 70% confidence over a short term horizon.
Impact figures are analytical estimates that combine direction, intensity, confidence and event importance. They are not investment advice.